NCM
MRK icon

Northwest Capital Management’s Merck MRK Stock Holding History

Northwest Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$192K Sell
1,821
-1,737
-49% -$163K 0.83% 37
2025
Q3 		$299K Sell
3,558
-10,530
-75% -$867K 0.31% 66
2025
Q2 		$1.12M Sell
14,088
-325
-2% -$25.8K 0.6% 42
2025
Q1 		$1.29M Sell
14,413
-962
-6% -$89.8K 0.53% 40
2024
Q4 		$1.53M Buy
15,375
+670
+5% +$69.1K 0.66% 32
2024
Q3 		$1.67M Sell
14,705
-792
-5% -$94.1K 0.6% 33
2024
Q2 		$1.92M Sell
15,497
-792
-5% -$102K 0.7% 27
2024
Q1 		$2.15M Buy
16,289
+8
+0% +$986 0.69% 27
2023
Q4 		$1.77M Buy
16,281
+155
+1% +$16.1K 0.6% 29
2023
Q3 		$1.66M Buy
16,126
+17
+0.1% +$1.83K 0.64% 28
2023
Q2 		$1.86M Buy
16,109
+16
+0.1% +$1.82K 0.78% 28
2023
Q1 		$1.71M Buy
16,093
+16
+0.1% +$1.73K 0.83% 29
2022
Q4 		$1.78M Buy
16,077
+19
+0.1% +$1.94K 0.95% 29
2022
Q3 		$1.38M Buy
16,058
+169
+1% +$15.1K 0.8% 31
2022
Q2 		$1.45M Buy
15,889
+1,481
+10% +$131K 0.76% 28
2022
Q1 		$1.18M Buy
14,408
+46
+0.3% +$3.63K 0.56% 38
2021
Q4 		$1.13M Buy
14,362
+622
+5% +$49.5K 0.53% 39
2021
Q3 		$1.11M Buy
13,740
+19
+0.1% +$1.45K 0.58% 32
2021
Q2 		$1.05M Sell
13,721
-485
-3% -$36.1K 0.59% 29
2021
Q1 		$1.04M Buy
14,206
+71
+0.5% +$5.24K 0.76% 25
2020
Q4 		$1.1M Buy
14,135
+17
+0.1% +$1.3K 0.82% 22
2020
Q3 		$1.12M Buy
14,118
+19
+0.1% +$1.49K 0.92% 20
2020
Q2 		$1.04M Buy
14,099
+18
+0.1% +$1.35K 0.91% 20
2020
Q1 		$1.03M Buy
14,081
+17
+0.1% +$1.34K 1.03% 22
2019
Q4 		$1.22M Hold
14,064
– – 1.12% 20
2019
Q3 		$1.13M Hold
14,064
– – 1.19% 20
2019
Q2 		$1.13M Sell
14,064
-61
-0.4% -$4.67K 1.23% 19
2019
Q1 		$1.12M Buy
14,125
+2,317
+20% +$173K 1.35% 18
2018
Q4 		$861K Buy
11,808
+72
+0.6% +$5.08K 1.21% 18
2018
Q3 		$794K Buy
+11,736
New +$748K 0.84% 23

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northwest Capital Management's MRK Position: Q4 2025 in Review

Northwest Capital Management reduced its Merck (MRK) stake by 49% in Q4 2025, selling an estimated $163K and leaving 1,821 shares worth $192K. The position accounts for 0.83% of the portfolio, ranked #37.

Northwest Capital Management first reported a position in MRK in Q3 2018 and has held it in 30 quarters since. The position peaked at $2.15M in Q1 2024. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Northwest Capital Management held 1,821 shares of Merck worth $192K as of Q4 2025.
  • Northwest Capital Management sold 1,737 Merck shares in Q4 2025, an estimated $163K.
  • Merck made up 0.83% of Northwest Capital Management's portfolio in Q4 2025, its #37 holding.
  • Northwest Capital Management first reported a position in Merck in Q3 2018 and has held it in 30 quarters since.
  • Northwest Capital Management's Merck position peaked at $2.15M in Q1 2024.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Northwest Capital Management's 13F filing for Q4 2025, filed 26 Jan 2026.